Marcin A. Jedryka

Hirszfeld Square 12
Wroclaw, DS 53413, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Integrating the Central Sensitization Inventory (CSI) into Neuropelveological Practice: A Systematic Review of Endometriosis and Overlapping Pelvic Pain Syndromes.

Integrating the Central Sensitization Inventory (CSI) into Neuropelveological Practice: A Systematic Review of Endometriosis and Overlapping Pelvic Pain Syndromes.

Journal: Journal of clinical medicine

Published: May 31, 2026

Superparamagnetic Iron Oxide Used Alone Is Non-Inferior to the Combination of Radioactive Tracer and Superparamagnetic Iron Oxide in Detecting Sentinel Lymph Nodes in Early-Stage Vulvar Cancer.

Superparamagnetic Iron Oxide Used Alone Is Non-Inferior to the Combination of Radioactive Tracer and Superparamagnetic Iron Oxide in Detecting Sentinel Lymph Nodes in Early-Stage Vulvar Cancer.

Journal: Cancers

Published: October 19, 2025

Estrogen receptor α expression in tumor-infiltrating lymphocytes from patients with endometrial cancer.

Estrogen receptor α expression in tumor-infiltrating lymphocytes from patients with endometrial cancer.

Journal: Oncology letters

Published: May 20, 2025

Diagnostic Value of Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Early-Stage Cervical Cancer: The Preliminary Clinical Experience.

Diagnostic Value of Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Early-Stage Cervical Cancer: The Preliminary Clinical Experience.

Journal: Journal of functional biomaterials

Published: March 16, 2025

Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights.

Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: February 05, 2025

Sentinel SENECA risk factors for unsuccessful bi-lateral sentinel lymph node mapping in endometrial cancer.

Sentinel SENECA risk factors for unsuccessful bi-lateral sentinel lymph node mapping in endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 13, 2025

One-Step Nucleic Acid Amplification Analysis of Sentinel Lymphatic Nodes in Endometrial Cancer Patients (EU-OSNA): A European Multicenter Diagnostic Accuracy Study.

One-Step Nucleic Acid Amplification Analysis of Sentinel Lymphatic Nodes in Endometrial Cancer Patients (EU-OSNA): A European Multicenter Diagnostic Accuracy Study.

Journal: Cancer medicine

Published: December 27, 2024

Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series.

Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series.

Journal: Virchows Archiv : an international journal of pathology

Published: December 02, 2024

Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Endometrial Cancer.

Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Endometrial Cancer.

Journal: International journal of molecular sciences

Published: November 24, 2024

SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in cervical cancer.

SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 07, 2024

The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas.

The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: November 02, 2024

Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases.

Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases.

Journal: Virchows Archiv : an international journal of pathology

Published: October 29, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026